Ensysce Biosciences, Inc.
ENSC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,729 | -$1,734 | -$1,946 | -$3,564 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $97 | $157 | $46 | $0 |
| Change in WC | $2,344 | -$1,225 | $183 | $2,753 |
| Other Non-Cash | -$577 | $95 | $9 | $48 |
| Operating Cash Flow | -$1,866 | -$2,707 | -$1,707 | -$764 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$124 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$124 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$40 | -$24 | -$47 | $0 |
| Stock Issued | $0 | $2,243 | $1,448 | $358 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,491 | -$353 | -$143 | -$245 |
| Financing Cash Flow | $1,451 | $1,866 | $1,258 | $113 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$538 | -$841 | -$450 | -$652 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,212 | $3,052 | $3,502 | $4,154 |
| End Cash | $1,673 | $2,212 | $3,052 | $3,502 |
| Free Cash Flow | -$1,990 | -$2,707 | -$1,707 | -$764 |